Teligent Approved for Generic Topicort Ointment

Teligent hope to launch the ointment sometime in the second quarter of 2016
Teligent hope to launch the ointment sometime in the second quarter of 2016

Teligent announced that the Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Desoximetasone Ointment, the generic version of Taro's Topicort

Desoximetasone is a topical steroid indicated for corticosteroid-responsive dermatoses. Topical corticosteroids share anti-inflammatory, anti-pruritic, and vasoconstrictive actions. They play a role in cellular signaling, immune function, inflammation and protein regulation.

RELATED: Topical Steroid Potencies

Desoximetasone will be available as a 0.25% strength ointment in 15g, 60g, and 100g tubes. It is expected to launch in the second quarter of 2016. 

For more information call (856) 697-1441 or visit Teligent.com.

Loading links....